Menopause Hormone Therapy (HRT) in Champaign, IL

Bioidentical hormones in Champaign: what it means

Behind the label "bioidentical hormone replacement therapy" is a plain idea: a hormone whose structure matches the body's own. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. FDA-approved versions of both are sold by prescription at retail pharmacies.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

For women in Champaign, a physician licensed in Illinois can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

At 15.8 OB-GYNs per 100,000 residents (14 listed in the NPI registry), Champaign sits near the national 17.8 and below Illinois's 20.2; 41% of the cities VevaMD covers have a lower rate. With about 7,532 women aged 45 to 64 living in Champaign, that is about 540 for each OB-GYN in the city, before counting any younger patients.

Counting the area around it, 60 OB-GYNs practice in Champaign or within 10 miles and 61 within 25 miles: 24.8 for every 100,000 of the 246,406 people who live within 25 miles, a dense supply. None of this replaces your own OB-GYN or a menopause doctor you trust; VevaMD adds an online route, with a physician licensed in Illinois reviewing your answers from home in Champaign.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11